GGrantIndex
Sort

21,281 grants matching influenza

Pn3Pase as an Effective Enzyme Therapeutic for Streptococcus Pneumoniae type 3 Infection

$299,450
Fikri Y Avci · Pneumotactix, Llc · R41 · FY2022 · AI

Pn3Pase as an Effective Enzyme Therapeutic for Streptococcus Pneumoniae type 3 Infection

$299,450
Fikri Y Avci · Pneumotactix, Llc · R41 · FY2021 · AI

Self-Administered Vaccination Electromechanical Device for Influenza

$299,441
Kevin Marchitto · Rocky Mountain Biosystems, Inc. · R43 · FY2007 · AI

Discovery of Critical Host Genes Enabling Resistance to HIV-1 Infection as Therap

$299,370
Hanwen Mao · Functional Genetics, Inc. · R43 · FY2007 · AI

Analysis of Novel Virus-Induced RNAs

$299,341
Curt M Horvath · Northwestern University · R01 · FY2015 · GM

Modular Sample Preparation for In-Field Viral Discovery

$299,326
Anja Sharma · Lynntech, Inc. · N43 · FY2023 · AI

Bile acid conjugates to improve the oral bioavailability of anti-influenza drugs

$299,314
Phillip Kish · Tsrl, Inc. · R43 · FY2006 · AI

Development of a Universal Influenza Vaccine

$299,218
David A Macleod · Biological Mimetics, Inc. · R43 · FY2020 · AI

Development of a Universal Influenza Vaccine

$299,218
David A Macleod · Biological Mimetics, Inc. · R43 · FY2021 · AI

Remodeled glycoprotein for broad protection against ebolaviruses

$299,186
M. Javad Aman · Integrated Biotherapeutics, Inc. · R43 · FY2019 · AI

Development of a novel human rhinovirus vaccine

$299,164
Gregory John Tobin · Biological Mimetics, Inc. · R43 · FY2011 · AI

CD8 T Cell Replicative Senescence: Impact on Aged Humans

$299,154
Rita Brickman Effros · University Of California Los Angeles · R01 · FY2006 · AG

Design of New Immunogens Based on Conserved Epitopes in the Influenza Virus...

$299,093
Peter Palese · Icahn School Of Medicine At Mount Sinai · P01 · FY2013 · AI

Simulation of Proton Translocation in Biomolecules

$299,091
Gregory A. Voth · University Of Chicago · R01 · FY2014 · GM

Enhanced Oral Vaccine Delivery Vehicle

$299,082
Sean N Tucker · Vaxart, Inc. · R43 · FY2007 · AI

A chikungunya Viral Replicon as a Platform for Antiviral Therapeutics

$299,076
David E. Levy · Columbia University Health Sciences · U54 · FY2014 · AI

Northeast Biodefense Center

$299,076
W. Ian Lipkin · Columbia University Health Sciences · U54 · FY2014 · AI

Analysis of Novel Virus-Induced RNAs

$299,051
Curt M Horvath · Northwestern University · R01 · FY2016 · GM

Tissue and neurobehavioral phenotyping core

$298,962
Karen M Ridge · Northwestern University At Chicago · P01 · FY2022 · AG

STRUCTURE-FUNCTION STUDIES OF MOLECULAR CHAPERONES

$298,946
Stanford University · R01 · FY2003 · GM

Flu Vaccine Production Using a Novel Pandemic Response and Prevention Manufacturing Method

$298,891
Michael Artinger · Solaris Vaccines, Inc. · R43 · FY2023 · AI

H.influenzae Hemoglobin/Hemoglobin-Haptoglobin Binding

$298,870
University Of Oklahoma Hlth Sciences Ctr · R01 · FY2001 · AI

Combinational Regulation of Inflammation in Otitis Media

$298,775
Jian-Dong Li · Georgia State University · R01 · FY2013 · DC

Quorum signal eavesdropping by Moraxella catarrhalis

$298,775
William E Swords · Wake Forest University Health Sciences · R01 · FY2013 · DC

Analysis of Novel Virus-Induced RNAs

$298,747
Curt M Horvath · Northwestern University · R01 · FY2017 · GM